A novel tumor suppressor network in squamous malignancies

Scientific Reports

Volumn 2, Issue , 2012, Pages

  Costa, Clotilde ^a   Santos, Mirentxu ^a   Segrelles, Carmen ^a   Dueñas, Marta ^a   Lara, M Fernanda ^a   Agirre, Xabier ^b   Prosper, Felipe ^b   García Escudero, Ramón ^a   Paramio, Jesús M ^a  

^a CIEMAT   (Spain)

^b UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MTOR PROTEIN, MOUSE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN P107; PROTEIN P53; PTEN PROTEIN, MOUSE; RBL1 PROTEIN, MOUSE; RETINOBLASTOMA PROTEIN; TARGET OF RAPAMYCIN KINASE;

ANIMAL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION; DRUG ANTAGONISM; GENE REGULATORY NETWORK; GENETICS; HUMAN; METABOLISM; MOUSE; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

ANIMALS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; GENE REGULATORY NETWORKS; GENES, TUMOR SUPPRESSOR; HUMANS; MICE; NEOPLASMS, SQUAMOUS CELL; PTEN PHOSPHOHYDROLASE; RETINOBLASTOMA PROTEIN; RETINOBLASTOMA-LIKE PROTEIN P107; TOR SERINE-THREONINE KINASES; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84869155458     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep00828     Document Type: Article

References (60)

1. Weinberg, R. A. The retinoblastoma protein and cell cycle control. Cell 81, 323-330 (1995).
2. Nevins, J. R. The Rb/E2F pathway and cancer. Hum Mol Genet 10, 699-703 (2001). (Pubitemid 32331578)
3. Clarke, A. R. et al. Requirement for a functional Rb-1 gene in murine development. Nature 359, 328-330 (1992).
4. Jacks, T. et al. Effects of an Rb mutation in themouse. Nature 359, 295-300 (1992).
5. Lee, E. Y. et al. Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis. Nature 359, 288-294 (1992).
6. Ruiz, S. et al. Unique and overlapping functions of pRb and p107 in the control of proliferation and differentiation in epidermis. Development 131, 2737-2748 (2004). (Pubitemid 38877905)
7. Ruiz, S. et al. Unexpected roles for pRb in mouse skin carcinogenesis. Cancer Res 65, 9678-9686 (2005). (Pubitemid 41541443)
8. Martinez-Cruz, A. B. et al. Spontaneous squamous cell carcinoma induced by the somatic inactivation of retinoblastoma and Trp53 tumor suppressors. Cancer Res 68, 683-692 (2008). (Pubitemid 351206743)
9. Martinez-Cruz, A. B. et al. Spontaneous tumor formation in Trp53-deficient epidermis mediated by chromosomal instability and inflammation. Anticancer research 29, 3035-3042 (2009).
10. Bornachea, O. et al. EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours. Scientific reports 2, 434 (2012).
11. Garcia-Escudero, R. et al. Gene expression profiling of mouse p53-deficient epidermal carcinoma defines molecular determinants of human cancer malignancy. Molecular cancer 9, 193 (2010).
12. Costa, C. et al. E2F1 loss induces spontaneous tumour development in Rb-deficient epidermis. Oncogene (2012) doi: 10.1038/onc.2012.316.
13. Lara, M. F. et al. p107 acts as a tumor suppressor in pRb-deficient epidermis. Mol Carcinog 47, 105-113 (2008). (Pubitemid 351231439)
14. Lara, M. F. et al. Gene profiling approaches help to define the specific functions of retinoblastoma family in epidermis. Mol Carcinog 47, 209-221 (2008). (Pubitemid 351398064)
15. Santos, M. et al. Susceptibility of pRb-deficient epidermis to chemical skin carcinogenesis is dependent on the p107 allele dosage. Mol Carcinog 47, 815-821 (2008).
16. Lara, M. F. & Paramio, J. M. The Rb family connects with the Tp53 family in skin carcinogenesis. Mol Carcinog 46, 618-623 (2007). (Pubitemid 47255177)
17. Stambolic, V. et al. Regulation of PTEN transcription by p53. Molecular cell 8, 317-325 (2001). (Pubitemid 32831549)
18. Vivanco, I. & Sawyers, C. L. The phosphatidylinositol 3-Kinase AKT pathway in human cancer. Nat Rev Cancer 2, 489-501 (2002). (Pubitemid 37328931)
19. Ming, M. & He, Y. Y. PTEN: new insights into its regulation and function in skin cancer. The Journal of investigative dermatology 129, 2109-2112 (2009).
20. Segrelles, C. et al. Functional roles of Akt signaling in mouse skin tumorigenesis. Oncogene 21, 53-64 (2002). (Pubitemid 34076378)
21. Ruiz, S. et al. Abnormal epidermal differentiation and impaired epithelialmesenchymal tissue interactions in mice lacking the retinoblastoma relatives p107 and p130. Development 130, 2341-2353 (2003). (Pubitemid 36722386)
22. Segrelles, C. et al. Deregulated Activity of Akt in Epithelial Basal Cells Induces Spontaneous Tumors and Heightened Sensitivity to Skin Carcinogenesis. Cancer Res 67, 10879-10888 (2007). (Pubitemid 350145917)
23. Segrelles, C. et al. Constitutively Active Akt Induces Ectodermal Defects and Impaired Bone Morphogenetic Protein Signaling. Molecular biology of the cell 19, 137-149 (2008). (Pubitemid 351186140)
24. Ruiz, S., Santos, M. & Paramio, J. M. Is the loss of pRb essential for themouse skin carcinogenesis? Cell Cycle 5, 625-629 (2006).
25. Hettinger, K. et al. c-Jun promotes cellular survival by suppression of PTEN. Cell death and differentiation 14, 218-229 (2007). (Pubitemid 46092225)
26. Leonard, M. K. et al. DeltaNp63alpha regulates keratinocyte proliferation by controlling PTEN expression and localization. Cell death and differentiation 18, 1924-1933 (2011).
27. Slebos, R. J. et al. Gene expression differences associated with human papillomavirus status in head and neck squamous cell carcinoma. Clin Cancer Res 12, 701-709 (2006). (Pubitemid 43259848)
28. Buitrago-Perez, A. et al. A Humanized Mouse Model of HPV-Associated Pathology Driven by E7 Expression. PLoS One 7, e41743 (2012).
29. Munger, K. et al. Biological activities and molecular targets of the human papillomavirus E7 oncoprotein. Oncogene 20, 7888-7898 (2001). (Pubitemid 33135315)
30. Wise-Draper, T. M. & Wells, S. I. Papillomavirus E6 and E7 proteins and their cellular targets. Front Biosci 13, 1003-1017 (2008). (Pubitemid 351594744)
31. Pyeon, D. et al. Fundamental differences in cell cycle deregulation in human papillomavirus-positive and human papillomavirus-negative head/neck and cervical cancers. Cancer Res 67, 4605-4619 (2007). (Pubitemid 46910165)
32. Li, M. et al.Distinct Regulatory Mechanisms and Functions for p53-Activated and p53-Repressed DNA Damage Response Genes in Embryonic Stem Cells. Molecular cell 46, 30-42 (2012).
33. Garcia-Escudero, R. & Paramio, J. M. Gene expression profiling of mouse epidermal keratinocytes. Methods in molecular biology (Clifton, N.J) 585, 171-181 (2010).
34. Greshock, J. et al. Molecular target class is predictive of in vitro response profile. Cancer Res 70, 3677-3686 (2010).
35. Herwig, S. & Strauss, M. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur J Biochem 246, 581-601 (1997). (Pubitemid 27252898)
36. Sellers, W. R. & Kaelin, W. G., Jr. Role of the retinoblastoma protein in the pathogenesis of human cancer. J Clin Oncol 15, 3301-3312 (1997). (Pubitemid 27485848)
37. Dannenberg, J. H., Schuijff, L., Dekker, M., van der Valk, M. & Riele, H. T. Tissuespecific tumor suppressor activity of retinoblastoma gene homologs p107 and p130. Genes Dev 18, 2952-2962 (2004). (Pubitemid 39602313)
38. Robanus-Maandag, E. et al. p107 is a suppressor of retinoblastoma development in pRb-deficient mice. Genes Dev 12, 1599-1609 (1998). (Pubitemid 28299512)
39. Dai, C. & Gu, W. p53 post-translational modification: deregulated in tumorigenesis. Trends in molecular medicine 16, 528-536 (2010).
40. Sykes, S. M. et al. Acetylation of the p53 DNA-binding domain regulates apoptosis induction. Molecular cell 24, 841-851 (2006). (Pubitemid 44960096)
41. Scoumanne, A. & Chen, X. Protein methylation: a new mechanism of p53 tumor suppressor regulation. Histol Histopathol 23, 1143-1149 (2008).
42. Moral, M. et al. Akt activation synergizes with Trp53 loss in oral epithelium to produce a novel mouse model for head and neck squamous cell carcinoma. Cancer Res 69, 1099-1108 (2009).
43. Shin, M. K., Pitot, H. C. & Lambert, P. F. Pocket proteins suppress head and neck cancer. Cancer Res 72, 1280-1289 (2012).
44. Garcia-Escudero, R. & Paramio, J. M. Gene expression profiling as a tool for basic analysis and clinical application of human cancer. Mol Carcinog 47, 573-579 (2008).
45. Menges, C. W., Baglia, L. A., Lapoint, R. &McCance, D. J. Human papillomavirus type 16 E7 up-regulates AKT activity through the retinoblastoma protein. Cancer Res 66, 5555-5559 (2006). (Pubitemid 43927104)
46. Leemans, C. R., Braakhuis, B. J.&Brakenhoff, R. H. The molecular biology of head and neck cancer. Nat Rev Cancer 11, 9-22 (2011).
47. Moral, M. & Paramio, J.M. Akt pathway as a target for therapeutic intervention in HNSCC. Histol Histopathol 23, 1269-1278 (2008).
48. Molinolo, A. A. et al. Dissecting the Akt/mammalian target of rapamycin signaling network: emerging results from the head and neck cancer tissue array initiative. Clin Cancer Res 13, 4964-4973 (2007). (Pubitemid 47502060)
49. Amornphimoltham, P. et al. Mammalian target of rapamycin, a molecular target in squamous cell carcinomas of the head and neck. Cancer Res 65, 9953-9961 (2005). (Pubitemid 41541476)
50. Molinolo, A. A. et al. Dysregulated molecular networks in head and neck carcinogenesis. Oral Oncol 45, 324-334 (2009).
51. Raimondi, A. R., Molinolo, A. & Gutkind, J. S. Rapamycin prevents early onset of tumorigenesis in an oral-specific K-ras and p53 two-hit carcinogenesis model. Cancer Res 69, 4159-4166 (2009).
52. Paramio, J.M., Navarro, M., Segrelles, C., Gomez-Casero, E.&Jorcano, J. L. PTEN tumour suppressor is linked to the cell cycle control through the retinoblastoma protein. Oncogene 18, 7462-7468 (1999). (Pubitemid 30035047)
53. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 98, 5116-5121 (2001). (Pubitemid 32397092)
54. Saeed, A. I. et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 34, 374-378 (2003). (Pubitemid 36184095)
55. Chen, H. Y. et al. A five-gene signature and clinical outcome in non-small-cell lung cancer. N Engl J Med 356, 11-20 (2007).
56. Dennis, G., Jr. et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4, P3 (2003).
57. Hosack, D. A., Dennis, G., Jr., Sherman, B. T., Lane, H. C. & Lempicki, R. A. Identifying biological themes within lists of genes with EASE. Genome Biol 4, R70 (2003).
58. Mootha, V. K. et al. PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature genetics 34, 267-273 (2003). (Pubitemid 36792858)
59. Subramanian, A. et al.Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 102, 15545-15550 (2005). (Pubitemid 41528093)
60. Rhodes, D. R. et al. Oncomine 3.0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles. Neoplasia 9, 166-180 (2007).